Abstract
Background
Small cell carcinomas are among the most aggressive, poorly differentiated, and highly malignant of the neuroendocrine tumors (NETs). Of which, small cell gastric carcinoma is a rare small cell neuroendocrine tumor. The purpose of our study was to present this case and perform a comprehensive literature review.
Methods and Results
We review a case of small cell gastric carcinoma that is particularly unusual in that it occurred in a woman from the US when the majority of cases of small cell gastric carcinoma have been reported in men from East Asia, and more specifically, from Japan. The diagnosis was made after endoscopy revealed a large ulcerated mass in the gastric cardia of Borrmann type 3. Biopsies revealed multiple small basophilic cells underlying the squamous epithelium of the esophagus and cardiac mucosa, indicating the presence of a tumor at the gastroesophageal junction. Immunostaining established the diagnosis with positive stains for chromogranin, synaptophysin, and CD56. Our patient is being treated with chemotherapy, but many different treatment regimens have been tried for small cell gastric carcinoma with variable success.
Conclusions
Overall prognosis for small cell gastric carcinoma is dismal. Neuroendocrine tumors in general have variable clinical behaviors and prognosis is dependent on the neuroendocrine tumor type. The adoption of a standardized classification system for neuroendocrine tumors could improve the recognition of infrequently encountered neuroendocrine tumors like small cell gastric carcinoma and will enhance strategies for treatment and thus improve prognosis for patients with these rare and aggressive tumors.
Similar content being viewed by others
References
Bajetta E, Catena L, Procopio G, Bichisao E, et al. Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Onc. 2005;16:1374–1380.
Wick MR. Neuroendocrine neoplasia: current concepts. Am J Clin Pathol. 2000;113:331–335.
Chejfec G, Gould VE. Malignant gastric neuroendocrinomas. Ultrastructural and biochemical characterization of their secretory activity. Hum Pathol. 1977;8:433–440.
Ibrahim NB, Briggs JC, Corbishley CM. Extrapulmonary oat cell carcinoma. Cancer. 1984;54:1645–1661.
Fer MF, Levenson Jr RM, Cohen MH, Greco FA. Extrapulmonary small cell carcinoma. In: Greco FA, Oldham RK, Bunn PA, eds. Small Cell Lung Cancer. New York: Grune & Stratton; 1981:301–326.
Iwamuro M, Tanaka S, Bessho A, Takahashi H, et al. Two cases of primary small cell carcinoma of the stomach. Acta Med Okayama. 2009;63:293–298.
Kusayanagi S, Konishi K, Miyasaka N, Sasaki K, et al. Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol. 2003;18:743–747.
Tanemura H, Ohshita H, Kanno A, Kusakabe M, et al. A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis. Int J Clin Oncol. 2002;7:128–132.
Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730–2739.
Shpaner A, Yusuf TE. Primary gastric small-cell neuroendocrine carcinoma. Endoscopy. 2007;39(Suppl 1):E310–E311.
Takeuchi H, Futamata K, Maeshima A, Hirose S, et al. A case of primary gastric small cell carcinoma with a rare pattern of lymph node metastasis. Int J Gastrointest Cancer. 2005;36:99–104.
Arai KMD, Matsuda MMD. Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol. 1998;21(5):458–461.
Badger SA, Lee J, Vazir H, Diamond T, Panesar KJ. Extra-pulmonary oat cell carcinoma: report of two cases. Ulster Med J. 2005;74:63–65.
Bravo E, Estraviz B, Landaluce A, Sarabia S. Small (oat)-cell carcinoma of the gastrointestinal tract. Cir Esp. 2008;83:153–155.
Bugalho P, Chorao M, Fontoura P. Miliary brain metastases from primary gastric small cell carcinoma: illustrating the seed and soil hypothesis. J Neurooncol. 2005;73:53–56.
Chaudhary UB, Taksey JD, Johnson RD, Lewin DN. Small-cell cancers, and an unusual reaction to chemotherapy: case 3. Small-cell carcinoma of the stomach. J Clin Oncol. 2003;21:2441–2442.
Chetty R, Weinreb I. Gastric neuroendocrine carcinoma arising from heterotopic pancreatic tissue. J Clin Pathol. 2004;57:314–317.
Cioppa T, Marrelli D, Neri A, Caruso S, et al. A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy. Eur J Cancer Care (Engl). 2007;16:453–457.
Hamano R, Hirao T, Tokuoka M, Masuzawa T, Shibata K, Kobayashi T. A case report of gastric small cell carcinoma with long survival time by adjuvant chemotherapy—reports of chemotherapy regimens for gastric small cell carcinoma. Gan To Kagaku Ryoho. 2007;34:609–613.
Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol. 2005;86:213–218.
Hasegawa S, Yamamoto Y, Ishiwa N, Yoshikawa T, et al. A case of small cell carcinoma of the stomach. Gan To Kagaku Ryoho. 2003;30:999–1002.
Hirano Y, Hara T, Nozawa H, Oyama K, et al. Combined choriocarcinoma, neuroendocrine cell carcinoma and tubular adenocarcinoma in the stomach. World J Gastroenterol. 2008;14:3269–3272.
Hosoya Y, Nagai H, Koinuma K, Yasuda Y, Kaneko Y, Saito K. A case of aggressive neuroendocrine carcinoma of the stomach. Gastric Cancer. 2003;6:55–59.
Hussein AM, Otrakji CL, Hussein BT. Small cell carcinoma of the stomach. Case report and review of the literature. Dig Dis Sci. 1990;35:513–518.
Kato T, Sato K, Tamahashi N, Yano H, Masuoka HO. A case of small cell carcinoma of the stomach. Gan To Kagaku Ryoho. 2005;32:1473–1475.
Koide N, Suzuki A, Saito H, Sato T, et al. Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case. Surg Today. 2007;37:989–994.
Kuo SC, Chao Y, Luo JC, Lee KC, et al. Primary small cell carcinoma of the stomach successfully treated with cisplatin and etoposide. J Chin Med Assoc. 2009;72:598–602.
Nakamura Y, Otani S, Otaka M, Shimada T, et al. Gastric small cell carcinoma with marked response to neoadjuvant chemotherapy. Int J Clin Oncol. 2005;10:348–352.
Namikawa T, Kobayashi M, Okabayashi T, Ozaki S, et al. Primary gastric small cell carcinoma: report of a case and review of the literature. Med Mol Morphol. 2005;38:256–261.
O’Byrne KJ, Cherukuri AK, Khan MI, Farrell RJ, et al. Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol. 1997;36:78–80.
Saeki H, Anegawa G, Masuda T, Ohta R, et al. A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy. Gan To Kagaku Ryoho. 2006;33:977–979.
Shimada M, Iwase H, Iyo T, Nakarai K, et al. A case of complete response in a primary lesion treated by combined chemotherapy of TS-1 and CDDP for small cell carcinoma of the stomach with liver metastasis. Gan To Kagaku Ryoho. 2004;31:593–596.
Takaku H, Oka K, Naoi Y, Santoh N, Setsu Y, Mori N. Primary advanced gastric small cell carcinoma: a case report and review of the literature. Am J Gastroenterol. 1999;94:1402–1404.
Yamaguchi T, Imamura Y, Nakayama K, Kawada T, Yamamoto T, Fukuda M. Paranuclear blue inclusions of small cell carcinoma of the stomach: report of a case with cytologic presentation in peritoneal washings. Acta Cytol. 2005;49:207–212.
Yamazaki K. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study. Virchows Arch. 2003;442:77–81.
Yata Y, Nakayama Y, Takahara T, Yamazaki K, et al. A case of small cell gastric carcinoma with an adenocarcinoma component operated curatively. Acta Med Okayama. 2004;58:275–278.
Tulchinsky M. F-18 FDG PET/CT in primary gastric small cell carcinoma. Clin Nucl Med. 2009;34:44–47.
Van Der Gaast A, Verwey J, Prins E, Splinter TA. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer. 1990;65:422–424.
Brouland JP, Manivet P, Brocheriou-Spelle I, Wassef M, et al. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component. Endocr Pathol. 2001;12:77–86.
Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010–1017.
Fenoglio-Preiser CM. Gastrointestinal neuroendocrine/neuroectodermal tumors. Am J Clin Pathol. 2001;115:S79–S93.
Watanabe N, Kato H, Shimizu M, Murakami J, et al. F-18 FDG PET imaging in gastric neuroendocrine carcinoma. Clin Nucl Med. 2006;31:345–346.
Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg. 2001;136:49–54.
Hosokawa A, Shimada Y, Shirao K, Matsumura Y, et al. Long-term survivor of gastric small cell carcinoma. Hepatogastroenterology. 2004;51:1567–1570.
Acknowledgments
This work was supported in part by the Physician Scientist Program award (to SG) at MD Anderson Cancer Center. We would like to thank Sue Moreau in the Department of Scientific Publications at the MD Anderson Cancer Center for reviewing this manuscript. The authors have no potential conflicts related to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richards, D., Davis, D., Yan, P. et al. Unusual Case of Small Cell Gastric Carcinoma: Case Report and Literature Review. Dig Dis Sci 56, 951–957 (2011). https://doi.org/10.1007/s10620-010-1404-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1404-1